go-v.orgdoi

π-π Stacked Polymeric Micelles: From Optimization to Early Preclinical Evaluation

Mahsa Bagheri · Utrecht University Repository (Utrecht University) · 2021

  • DOI 10.33540/618
  • Publisher Utrecht University
  • Type dissertation
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Utrecht University Repository (Utrecht University) · Utrecht University · dissertation · 2021

Abstract

Curcumin is a natural compound that is under investigation as a potential anti-cancer agent.However, its low aqueous solubility and extensive biotransformation by the intestine and liver as well as rapid renal excretion account for poor bioavailability and pharmacokinetics, which hampers its pharmaceutical application.Considerable efforts have been made to improve curcumin pharmacokinetics and prolong its exposure to diseased tissues by formulating it in nano-sized delivery systems.In this review, the pharmacokinetic profiles of intravenously administrated curcumin in free form and as nanoformulation in two preclinical animal models (mice and rats) are comprehensively analyzed.Thus, the impact of the variable absorption step on bioavailability is excluded providing a more precise overview of curcumin circulation kinetics and therapeutic efficacy.Interestingly, the results indicate that the majority of the nanoformulations improves the area under the curve (AUC) of curcumin only slightly between 1.3-5 folds higher than the free form.This means that curcumin is not well retained in the particles and thus they essentially act as solubilizers for this compound.Also, in studies which report both pharmacokinetics (PK) and pharmacodynamic (PD) data, curcumin nanoformulations result in stronger tumor growth inhibition than the free form in line with the slightly improved pharmacokinetics.A negative trend is observed between the total injected dose and relative tumor growth inhibition (%TGI) in treatment groups receiving curcumin nanoformulations and free curcumin, possibly due to tumor inhibition at higher dose regimen even for free curcumin with unfavorable PK.Furthermore, notable PD effects are not exclusively observed for the more stable nanoformulations and thus solubilization is sufficient for tumor growth inhibition.This review sheds light onto the current status of nanosized delivery systems for improving curcumin PK, highlights common weaknesses in study designs and brings the reader's attention to important factors (yet often neglected) affecting curcumin pharmacokinetics.

Open the resolved locator · 10.33540/618

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 04:38 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.33540/618
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.